phase readout
saveNCT07464366: The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic Salivary Gland Cancer: a Single-center, Open-label Cohort Study
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Ji Dongmei. Phase: PHASE2. Conditions: Salivary Gland Carcinomas
view source ↗
comments(0)
5-min edit window · permanent after that